Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of Conversion from Twice-Daily to Once-Daily Tacrolimus in Kidney Transplant Patients
TCTR20210715002Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Nov 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in Kidney allograft status (RTx), sponsored by Ratchadaphiseksomphot Endowment Fund. Started Nov 2019; status: completed.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on TCTR20210715002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210715002.